Rein Therapeutics, Inc.
Pharmaceutical Preparations · AUSTIN · TX
Moderate confidence (50%)
Updated Oct 13, 2026, 12:05 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Rein Therapeutics, Inc. received a delisting notice from its exchange (Aug 21, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Rein Therapeutics, Inc. received a delisting notice from its exchange
Aug 21, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 21, 2026, Rein Therapeutics, Inc. ( Company ) received a notice of delisting (the Notice ) from the Nasdaq Stock Market, LLC. The Notice stated that the Company had fallen below compliance with respect to the continued listing standard set forth in Rule 5550(a)(1) of the Nasdaq Listing Rules because the closing bid price of the Company s common stock over the previous 30 consecutive trading-day period had fallen below $1.00 per share. Pursuant to the notice and Rule 5810(c)(…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker RNTX on Nasdaq.
- SEC CIK
- 0001420565
- Website
- —
- —
- Headquarters
- AUSTIN, TX
- Also known as
- Aileron Therapeutics, Inc.
- Legal entities
- Rein Therapeutics, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Rein Therapeutics, Inc. — Pharmaceutical Preparations (SIC 2834) — AUSTIN, TX
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 21, 2026, Rein Therapeutics, Inc. ( Company ) received a notice of delisting (the Notice ) from the Nasdaq Stock Market, LLC. The Notice stated that the Company had fallen below compliance with respect to the continued listing standard set forth in Rule 5550(a)(1) of the Nasdaq Listing Rules because the closing bid price of the Company s common stock over the previous 30 consecutive trading-day period had fallen below $1.00 per share. Pursuant to the notice and Rule 5810(c)(…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:13 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 13, 2026, 12:04 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:36 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.